Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,901

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis

Open access
Chimowitz, Marc I., Lynn, Michael J., Derdeyn, Colin P., Turan, Tanya N., Fiorella, David, Lane, Bethany F., Janis, L. Scott, Lutsep, Helmi L., Barnwell, Stanley L., Waters, Michael F., Hoh, Brian L., Hourihane, J. Maurice, Levy, Elad I., Alexandrov, Andrei V., Harrigan, Mark R., Chiu, David, Klucznik, Richard P., Clark, Joni M., McDougall, Cameron G., Johnson, Mark D., Pride, G. Lee, Torbey, Michel T., Zaidat, Osama O., Rumboldt, Zoran, Cloft, Harry J.·2011·New England Journal of Medicine

Abstract

BACKGROUND: Atherosclerotic intracranial arterial stenosis is an important cause of stroke that is increasingly being treated with percutaneous transluminal angioplasty and stenting (PTAS) to prevent recurrent stroke. However, PTAS has not been compared with medical management in a randomized trial. METHODS: We randomly assigned patients who had a recent transient ischemic attack or stroke attributed to stenosis of 70 to 99% of the diameter of a major intracranial artery to aggressive medical management alone or aggressive medical management plus PTAS with the use of the Wingspan stent system. The primary end point was stroke or death within 30 days after enrollment or after a revascularization procedure for the qualifying lesion during the follow-up period or stroke in the territory of the qualifying artery beyond 30 days. RESULTS: Enrollment was stopped after 451 patients underwent randomization, because the 30-day rate of stroke or death was 14.7% in the PTAS group (nonfatal stroke, 12.5%; fatal stroke, 2.2%) and 5.8% in the medical-management group (nonfatal stroke, 5.3%; non-stroke-related death, 0.4%) (P=0.002). Beyond 30 days, stroke in the same territory occurred in 13 patients in each group. Currently, the mean duration of follow-up, which is ongoing, is 11.9 months. The probability of the occurrence of a primary end-point event over time differed significantly between the two treatment groups (P=0.009), with 1-year rates of the primary end point of 20.0% in the PTAS group and 12.2% in the medical-management group. CONCLUSIONS: In patients with intracranial arterial stenosis, aggressive medical management was superior to PTAS with the use of the Wingspan stent system, both because the risk of early stroke after PTAS was high and because the risk of stroke with aggressive medical therapy alone was lower than expected. (Funded by the National Institute of Neurological Disorders and Stroke and others; SAMMPRIS ClinicalTrials.gov number, NCT00576693.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1105335

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 1,901

Metadata

Authors
Chimowitz, M. I., Lynn, M. J., Derdeyn, C. P., Turan, T. N., Fiorella, D., Lane, B. F., Janis, L. S., Lutsep, H. L., Barnwell, S. L., Waters, M. F., Hoh, B. L., Hourihane, J. M., Levy, E. I., Alexandrov, A. V., Harrigan, M. R., Chiu, D., Klucznik, R. P., Clark, J. M., McDougall, C. G., Johnson, M. D., Pride, G. L., Torbey, M. T., Zaidat, O. O., Rumboldt, Z., & Cloft, H. J.
Venue
New England Journal of Medicine
Published
2011-09-15
Volume
365
Issue
11
Pages
993-1003
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2123634131
Cited by
1,901
References
1
FWCI
114.07
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis. https://app.cochat.ai/papers/10.1056/nejmoa1105335
The paper
Chimowitz, M. I., Lynn, M. J., Derdeyn, C. P., Turan, T. N., Fiorella, D., Lane, B. F., Janis, L. S., Lutsep, H. L., Barnwell, S. L., Waters, M. F., Hoh, B. L., Hourihane, J. M., Levy, E. I., Alexandrov, A. V., Harrigan, M. R., Chiu, D., Klucznik, R. P., Clark, J. M., McDougall, C. G., . . . Cloft, H. J. (2011). Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1105335

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.